Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Overview of attention for article published in Lancet Neurology, November 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 1 X user
patent: 11 patents

facebook: 6 Facebook pages
wikipedia: 3 Wikipedia pages
reddit: 1 Redditor

Readers on

mendeley: 338 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 11 patents that reference this research output.

LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

Application EP-4647123-A2

European Patent Office

12 Nov 2025

LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS IN A…

Application WO-2024121173-A1

World Intellectual Property Organisation (WIPO)

13 Jun 2024

Reducing systemic regulatory T cell levels or activity for treatment of a retinal…

Grant US-11643464-B2

United States of America

09 May 2023

Methods for treating amyotrophic lateral sclerosis

Grant US-11452724-B2

United States of America

27 Sep 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.